Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
about
The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-Ubc13-dependent ubiquitination events at DNA double strand breaksThe Anti-inflammatory Role of Endometase/Matrilysin-2 in Human Prostate Cancer CellsGelatinase B/MMP-9 in Tumour Pathogenesis and ProgressionInvolvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosisGlycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesThe Function and Roles of ADAMTS-7 in Inflammatory DiseasesFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesBlood-brain barrier breakdown in acute and chronic cerebrovascular diseaseSelective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal CancerHydrophilic extract from Posidonia oceanica inhibits activity and expression of gelatinases and prevents HT1080 human fibrosarcoma cell line invasionInsufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout miceHepatoprotective effect of MMP-19 deficiency in a mouse model of chronic liver fibrosisDIDS prevents ischemic membrane degradation in cultured hippocampal neurons by inhibiting matrix metalloproteinase releaseMatrix Metalloproteinase-10 (MMP-10) Interaction with Tissue Inhibitors of Metalloproteinases TIMP-1 and TIMP-2: BINDING STUDIES AND CRYSTAL STRUCTURESynthesis and in Vitro and in Vivo Evaluation of MMP-12 Selective Optical ProbesEndothelial Response to Glucocorticoids in Inflammatory DiseasesMatrix metalloproteinases in inflammatory bowel disease: an updateMultifaceted role of matrix metalloproteinases (MMPs)Emerging targets in neuroinflammation-driven chronic painBiochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decadeInsights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculationsMetalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulationInhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte CulturesPyrone-Based Inhibitors of Metalloproteinase Types 2 and 3 May Work as Conformation-Selective InhibitorsA disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implicationsUltrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes.The Concise Guide to PHARMACOLOGY 2013/14: enzymes.POVME: an algorithm for measuring binding-pocket volumes.VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissueRegulation of the basement membrane by epithelia generated forces.Optimization of total protein and activity assays for the detection of MMP-12 in induced human sputum.MMP19 is essential for T cell development and T cell-mediated cutaneous immune responsesEffects of detergents on catalytic activity of human endometase/matrilysin 2, a putative cancer biomarkerProgress in matrix metalloproteinase research.Altered serum level of cartilage oligomeric matrix protein and its association with coronary calcification in patients with coronary heart diseaseBroad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in miceMetalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.A macrophage cell model for selective metalloproteinase inhibitor designExtracellular matrix molecules: potential targets in pharmacotherapy.Effects of novel semiselective matrix metalloproteinase inhibitors on ex vivo cardiac structure-function.
P2860
Q24309142-A3F72974-4118-4611-9097-D7EE13D8F2A4Q24338163-BCB20822-7F91-449C-9513-F03E86DF8CA9Q24568374-31D0A34A-316F-47E7-92F8-ACCF64FA1D5DQ26744390-BB8E6D70-FDB7-4708-95A4-7FA9ECF3CA56Q26745510-CB0A36A6-18C2-4162-A282-E80F6D64275EQ26773190-AB6B31F2-C763-4DB0-B6F9-056CC6BA65EBQ26779933-6ABE7E10-1B2F-4574-A7BF-3F8882C4DC11Q27010013-773CF1AC-63BE-46D9-B08D-7374EA45D5DEQ27306938-47AB6934-2E79-4234-8C6B-42EFF2F267AEQ27311200-EDC834B9-DE24-4EDF-99B7-88F03D7D23C1Q27313841-72EC9B59-6638-4225-9031-59079D58C89EQ27316480-CCF0A87E-50A3-45EF-BB0F-4EB432463197Q27321544-45957663-E868-48D5-B930-9C2353EEDA36Q27678085-958FFC36-5A9B-44FD-8321-3C60D048DBD8Q27727742-29B47150-C381-4835-B52C-63D30E3D0A8DQ28073947-1378836F-EB52-4669-9D92-0096029845ECQ28080664-F3A0E70D-5373-4056-BF62-B4A39AD562CCQ28083906-39FB0B99-D53E-4A22-B214-817465ED19BAQ28242435-326823E9-69FC-49D0-94CC-59786E36C842Q28288148-6A7E9C47-7F2C-4D49-8208-012CFED0E8DEQ28477370-6EE2A79B-163B-402F-813E-ACD3DD1A575CQ28512433-9A557B13-FAAC-4C6B-BB76-BA65ACE10E24Q28547985-E6F54C5F-D7BF-4E3A-B47D-E7753B6E9CB2Q30039761-EAD62CA9-454A-459C-9DEB-3E711A51E0BCQ30430629-77374734-38FC-42AD-ADE5-55C86B3E87D6Q30449753-56C59C82-9C53-4CC8-BB0B-DD868F60C7EDQ30486745-30DC1098-91CD-4695-8FE2-2C1C93DB827FQ30499011-6E709071-3C93-49A3-84EE-CF466CBB9B97Q30528882-3F3FAB39-CD6F-4AE0-A147-C6AF2E1E6A90Q30530312-1E272A9E-5BEE-42C9-BA7D-73BC33222924Q30986676-D75333B9-3A2C-460F-B734-A937AD4DCCBEQ33340257-7924A2CC-28E8-42FC-8B69-B0F347852699Q33568669-A9440766-8662-497B-A1D2-4CD01EAE6032Q33608536-3C290580-7C48-4335-8A95-D8570EAB4782Q33615432-26366FE1-01ED-4BAC-874F-CD7C193DAE2EQ33622449-AAA13D12-5E89-44B2-A31F-097C62046701Q33660754-34D6BCD5-4D02-400F-96AF-DDF4BC1DBA76Q33680972-55AF9B07-58BD-40CB-8A49-0E3DD665D66DQ33694487-69375AF4-99D7-480A-BCD7-CDCD1A010DA2Q33715912-BCD028B2-9C9C-4C51-9104-3C6C3DF8E099
P2860
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
@en
type
label
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
@en
prefLabel
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
@en
P2860
P356
P1476
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
@en
P2093
Jialiang Hu
Qing-Xiang A Sang
P2860
P2888
P304
P356
10.1038/NRD2308
P577
2007-06-01T00:00:00Z